Pharma Investment in Digital Health: Strategies for success (2016)

Successfully Investing in Digital Health: a Guide for Pharma

It’s a strategic imperative for pharma to use its market position and money to shape and control the rapidly growing digital health space.Internal investment in digital health technology may be too little and acquisitions of established players could be too late and costly.

The operational benefits of digital health in terms of clinical trials, patient engagement, real world data and efficient workflow processes must be realised early. It’s time for pharma to step up to the plate. But when is a deal a good deal? Which funding model is optimal and in what circumstances? What are the attributes of an ideal startup investment partner?

For answers to these critical questions look no further than Pharma Investment in Digital Health: Strategies for success. The report reviews the latest 2016 deals and through expert insight identifies the critical strategic and tactical issues pharma must address if digital health investment is to bring both operational advantage and commercial ROI.

This report is available for immediate download after purchase -- buy your report now

Key Features

Unique and in-depth interviews with senior US and EU industry and investment executives who are spearheading this area of expansion
Review of notable deals and the US$3.9 billion digital health investment landscape in 1H 2016
Tables identifying “must haves” and danger areas for a successful investment partnership
Illustrations of digital health deals and case studies such as GE Ventures’ collaboration with digital health incubator StartUp Health
At-a-glance summaries of all the main conclusions and action points

Key Benefits

Understand why pharma’s investment in digital health technology is critical
Know in what areas pharma is investing its money
Evaluate how and when Partnerships, Joint Ventures, Startup Accelerators, Venture Capital and Corporate Venture Capital should be the investment vehicle of choice
Identify the key attributes of an ideal investment partner and the creative team behind it
Develop a cohesive strategy and management team around investing in digital health

Understand the key elements for a successful digital health investment strategy - Download now

Key Questions Answered By This Report:

Core Competence: Why is pharma’s investment in digital health so strategically important?
Fast Growth: There have been 231 deals worth US$3.9 billion in the first half of 2016 – which sectors are attracting most investor interest and what can you learn?
Successful Startup: What are the key investment criteria pharma should look for in a startup company?
Which Structure? Partnerships, Joint Ventures, Startup Accelerators, Venture Capital and Corporate Venture Capital. Which investment vehicles are right for your business and why?
Merck: Why is the Merck Global Health Innovation Fund considered to be a market leader in pharma corporate venturing in digital health?
Targeted Approach: Which digital health technologies should pharma invest in?
Resources: What organisational changes are needed if pharma is to recruit and build a successful investment teams?

Do you need to understand the investment options in digital health? Download now

Expert Views

Brett Davis, General Manager for ConvergeHEALTH by Deloitte, Deloitte Consulting, US
Ricardo dos Santos, Director, 4iNNO, US
Kristian Hart-Hansen, CEO, LEO Innovation Lab, Denmark
Ulrich Muehlner, Founder & Managing Director, GrowthCube Partners LLC, Switzerland
Tony Romito, Managing Director, Accenture Life Sciences, US
Steve Seuntjens, Partner, PHS Fund, Netherlands
Ruchita Sinha, Director, GE Ventures, Healthcare, US
Marc Sluijs, Digital Health Investment Advisor, Switzerland

Leading pharma and investment experts tackle key issues - buy your report now

Who will benefit from this report?

Pharma’s investment venture capital fund executives building or managing digital investment portfolios
Senior corporate finance managers who determine strategy and investment fund resources
Operational marketing, medical affairs and clinical research managers needing funding to drive change with digital health technology
Entrepreneurs seeking investment and support for their innovative digital health technology
Investment managers in finance houses looking for joint venture or deal brokerage opportunities in the digital health space

Report available for immediate download -- place your order today

Content Highlights

Overview of venture capital funding and investment in the digital health sector
Pharma moves from customer to digital health investor

Pharma’s venture capital funding in digital health
Pharma’s Joint Ventures with tech companies for Research & Development
Mergers & Acquisitions
Accelerators: supporting the startup ecosystem

Opportunities and challenges in partnering with startups
Keys to successful pharma and startup partnerships

Finding the right technology startup for investment
Advice for entrepreneurs
Choosing the right type of investor: pharma corporate VC versus experienced tech company VC

Critical needs for investing in digital health

Digital health will impact pharma’s core business, new business models are needed
Pharma needs data that digital health provides to justify the value of therapies
Pharma can leverage digital health to enhance drug treatment and improve behaviour
Pharma motivated to compete with tech giants leading digital health

The future of pharma investment in digital health technology

Regulatory climate for pharma investment in digital health is rapidly evolving
Emerging corporate venturing models present new opportunities
The future model of venture investment for pharma companies is not yet clear

2017 and beyond

This critical intelligence is available for immediate download — order your copy now

Need more information? Contact a consultant for an executive summary and sample pages from the report.

Get this report now